Literature DB >> 7551343

Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer.

L Nakopoulou1, A C Lazaris, D Baltas, I Giannopoulou, N Kavantzas, A Tzonou.   

Abstract

Determination of steroid receptors and several oestrogen-regulated proteins in mammary carcinomas is useful in the prediction of their evolution and of the likely success of endocrine therapy. Cathepsin D (Cat D), pS2 peptide and heat shock protein 27 (Hsp 27) were detected immunohistochemically in 63 infiltrating ductal (NOS) breast carcinomas, and our results were qualitatively correlated with several clinicopathological indicators and patients' overall survival. Cat D immunostaining of tumour cells was strongly associated with axillary nodal involvement (Pf = 0.0005) and so, it is directly connected with the metastatic capacity of malignant cells. pS2 immunoreactivity was correlated with oestrogen and progesterone receptor positivity (Pf = 0.0009 and Pf = 0.05 respectively) and, nonsignificantly, with good differentiation of the tumours (Pf = 0.06). Neoplastic cells expressing this protein are therefore characterised by a highly organised state of cellular physiology. Hsp 27 was expressed predominantly in tumours with one to four infiltrated lymph nodes (Pt = 0.05), and Hsp 27-positive patients were inclined to rather short survival, possibly due to chemotherapy resistance. In future, prognostic estimation of each one of the examined markers should be performed in specific large subgroups of patients. The findings of this study contribute to the establishment of criteria by which these subgroups should be formed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551343     DOI: 10.1007/bf00203735

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Complete primary structure of the human estrogen-responsive gene (pS2) product.

Authors:  K Mori; R Fujii; N Kida; H Takahashi; S Ohkubo; M Fujino; M Ohta; K Hayashi
Journal:  J Biochem       Date:  1990-01       Impact factor: 3.387

2.  pS2 protein and steroid hormone receptors in invasive breast carcinomas.

Authors:  F C Koerner; D E Goldberg; S M Edgerton; L H Schwartz
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

3.  Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers.

Authors:  F K Storm; D M Mahvi; K W Gilchrist
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

4.  Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma.

Authors:  I Kardaś; G Seitz; J Limon; A Niezabitowski; J Ryś; B Theisinger; C Welter; N Blin
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

5.  Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer.

Authors:  P L Kandalaft; K L Chang; C W Ahn; S T Traweek; P Mehta; H Battifora
Journal:  Cancer       Date:  1993-05-01       Impact factor: 6.860

6.  Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations.

Authors:  A Thor; C Benz; D Moore; E Goldman; S Edgerton; J Landry; L Schwartz; B Mayall; E Hickey; L A Weber
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

7.  A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.

Authors:  P Pujol; T Maudelonde; J P Daures; P Rouanet; J P Brouillet; H Pujol; H Rochefort
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

8.  Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.

Authors:  V Cappelletti; D Coradini; E Scanziani; E Benini; R Silvestrini; G Di Fronzo
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

9.  Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo.

Authors:  D P Edwards; P A Estes; V A Fadok; B J Bona; S Oñate; S K Nordeen; W J Welch
Journal:  Biochemistry       Date:  1992-03-10       Impact factor: 3.162

10.  Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.

Authors:  A Scorilas; J Yotis; D Gouriotis; A Keramopoulos; K Ampela; T Trangas; M Talieri
Journal:  Anticancer Res       Date:  1993 Sep-Oct       Impact factor: 2.480

View more
  1 in total

1.  Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay.

Authors:  Jung-Hee Lee; Dongil Sun; Kwang-Jae Cho; Min-Sik Kim; Myung-Hwa Hong; In-Kyung Kim; Jae-Seon Lee; Jeong-Hwa Lee
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-12       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.